AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
The Largest Healthcare Companies by Market Cap in August 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
My 3 Favorite Stocks to Buy Right Now
These tried-and-true businesses are performing well against a volatile backdrop.
Investing in Pharmaceutical Stocks
4 of My Favorite Dividend Stocks for the Next 5 Years
All four pay safe, reliable, and growing dividends.
3 Stocks Retirees Should Absolutely Love
These stocks check off all the boxes for investors no longer receiving a paycheck.
AbbVie Raises 2025 Outlook After Q2 Beat
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
Spoiler: You would have done well -- and even better if you'd reinvested your dividends.
3 Unstoppable Stocks to Buy in August
Here are hot stocks to buy in a hot month.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q2 2025 Earnings Call Transcript
None
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2024.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.